• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-8表达对接受放疗或放化疗的头颈鳞状细胞癌患者的预测能力。

Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.

作者信息

León Xavier, García Jacinto, Farré Nuria, Majercakova Katarina, Avilés-Jurado Francesc-Xavier, Quer Miquel, Camacho Mercedes

机构信息

Servicio de Otorrinolaringología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.

Servicio de Otorrinolaringología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

出版信息

Acta Otorrinolaringol Esp (Engl Ed). 2021 Nov-Dec;72(6):337-343. doi: 10.1016/j.otoeng.2020.05.006.

DOI:10.1016/j.otoeng.2020.05.006
PMID:34844671
Abstract

OBJECTIVE

To analyse the relationship between the transcriptional expression of interleukin-8 (IL-8) and response to treatment with radiotherapy or chemo-radiotherapy in patients with squamous cell carcinoma of the head and neck (SCCHN).

MATERIAL AND METHODS

Retrospective study from tumour biopsies obtained before a treatment with radiotherapy or chemo-radiotherapy in 87 patients with SCCHN. We had a sample of healthy mucosa in 35 cases. We determined the transcriptional expression of IL-8 with RT-PCR. The transcriptional expression of IL-8 was categorized according to the local control of the disease with a recursive partitioning analysis.

RESULTS

The transcriptional expression of IL-8 in tumour tissue was about 50 times higher than that in the samples of healthy mucosa. Patients with a high transcriptional expression of IL-8 (n = 56) had a 5-year local recurrence-free survival of 65.6%, and for patients with low expression (n = 31) it was 90.2% (P = 0.017). According to the results of a multivariate analysis, patients with high expression of IL-8 had a 4.1 higher risk of local recurrence of the tumour.

CONCLUSIONS

SCCHN have a significant increase in transcriptional expression of IL-8 in relation to non-tumour tissue. Tumours with high IL-8 expression have an increased risk of local recurrence after treatment with radiotherapy or chemo-radiotherapy.

摘要

目的

分析头颈部鳞状细胞癌(SCCHN)患者白细胞介素-8(IL-8)的转录表达与放疗或放化疗治疗反应之间的关系。

材料与方法

对87例接受放疗或放化疗治疗前获取肿瘤活检组织的SCCHN患者进行回顾性研究。35例患者有健康黏膜样本。采用逆转录聚合酶链反应(RT-PCR)测定IL-8的转录表达。通过递归分割分析,根据疾病的局部控制情况对IL-8的转录表达进行分类。

结果

肿瘤组织中IL-8的转录表达比健康黏膜样本中的高约50倍。IL-8转录表达高的患者(n = 56)5年局部无复发生存率为65.6%,而表达低的患者(n = 31)为90.2%(P = 0.017)。根据多因素分析结果,IL-8高表达患者肿瘤局部复发风险高4.1倍。

结论

与非肿瘤组织相比,SCCHN中IL-8的转录表达显著增加。IL-8高表达的肿瘤在放疗或放化疗治疗后局部复发风险增加。

相似文献

1
Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.白细胞介素-8表达对接受放疗或放化疗的头颈鳞状细胞癌患者的预测能力。
Acta Otorrinolaringol Esp (Engl Ed). 2021 Nov-Dec;72(6):337-343. doi: 10.1016/j.otoeng.2020.05.006.
2
Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.白细胞介素-8表达对接受放疗或放化疗的头颈部鳞状细胞癌患者的预测能力。
Acta Otorrinolaringol Esp (Engl Ed). 2020 Sep 21. doi: 10.1016/j.otorri.2020.05.003.
3
Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy.预测头颈部鳞状细胞癌患者接受放疗后 FAT1 转录表达的能力。
Acta Otorrinolaringol Esp (Engl Ed). 2023 Nov-Dec;74(6):359-364. doi: 10.1016/j.otoeng.2023.03.008. Epub 2023 Nov 4.
4
Predictive value of transcriptional expression of Krüppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy.转录表达因子 Krüppel 样因子-6(KLF6)对头颈部癌患者放疗疗效的预测价值。
Clin Transl Oncol. 2021 Dec;23(12):2507-2512. doi: 10.1007/s12094-021-02651-4. Epub 2021 Jun 1.
5
Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy.头颈部鳞状细胞癌患者放疗后 PIM1 转录表达与局部控制的关系。
Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3679-3684. doi: 10.1007/s00405-021-07223-4. Epub 2022 Jan 6.
6
F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival.基于 F-FDG-PET/CT 的头颈部鳞状细胞癌根治性(放)化疗治疗计划可改善区域性控制和生存。
Radiother Oncol. 2020 Jan;142:107-114. doi: 10.1016/j.radonc.2019.07.025. Epub 2019 Aug 19.
7
Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.头颈部鳞状细胞癌放疗后复发的挽救性手术。
Otolaryngol Head Neck Surg. 2019 Jun;160(6):1023-1033. doi: 10.1177/0194599818818443. Epub 2018 Dec 11.
8
Use of Diffusion-Weighted Imaging and F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.弥散加权成像和 F-氟代脱氧葡萄糖正电子发射断层扫描与计算机断层扫描联合应用于头颈部鳞状细胞癌放化疗反应评估。
Clin Oncol (R Coll Radiol). 2018 Dec;30(12):780-792. doi: 10.1016/j.clon.2018.09.007. Epub 2018 Oct 11.
9
Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy.FNDC4 转录表达对头颈癌患者放化疗预后的价值。
Clin Transl Oncol. 2022 Nov;24(11):2175-2180. doi: 10.1007/s12094-022-02870-3. Epub 2022 Jun 25.
10
Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.当已知临床 T 分期时,预处理 ADC 不是头颈部鳞状细胞癌局部复发的预后因素。
Eur Radiol. 2020 Feb;30(2):1228-1231. doi: 10.1007/s00330-019-06426-y. Epub 2019 Sep 16.

引用本文的文献

1
CMTM4 promotes the motility of colon cancer cells under radiation and is associated with an unfavorable neoadjuvant chemoradiotherapy response and patient survival in rectal cancer.CMTM4促进辐射条件下结肠癌细胞的迁移,且与直肠癌新辅助放化疗反应不佳及患者生存率相关。
Oncol Lett. 2025 Jan 10;29(3):138. doi: 10.3892/ol.2025.14884. eCollection 2025 Mar.
2
Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models.趋化因子受体CXCR1和CXCR2的抑制与多西他赛协同作用,可有效控制HPV阴性头颈癌模型的肿瘤并重塑其免疫微环境。
J Exp Clin Cancer Res. 2024 Dec 5;43(1):318. doi: 10.1186/s13046-024-03240-3.
3
Curcumin: A Potential Weapon in the Prevention and Treatment of Head and Neck Cancer.姜黄素:头颈癌预防与治疗中的一种潜在武器。
ACS Pharmacol Transl Sci. 2024 Oct 14;7(11):3394-3418. doi: 10.1021/acsptsci.4c00518. eCollection 2024 Nov 8.
4
The Assessment of Serum Cytokines in Oral Squamous Cell Carcinoma Patients: An Observational Prospective Controlled Study.口腔鳞状细胞癌患者血清细胞因子的评估:一项前瞻性观察性对照研究。
J Clin Med. 2022 Sep 14;11(18):5398. doi: 10.3390/jcm11185398.